BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24763974)

  • 1. Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B.
    Athale AH; Marcucci M; Iorio A
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010561. PubMed ID: 24763974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B.
    Olasupo OO; Lowe MS; Krishan A; Collins P; Iorio A; Matino D
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014201. PubMed ID: 34407214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011385. PubMed ID: 31002742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery.
    Coppola A; Windyga J; Tufano A; Yeung C; Di Minno MN
    Cochrane Database Syst Rev; 2015 Feb; (2):CD009961. PubMed ID: 25922858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors.
    Chai-Adisaksopha C; Nevitt SJ; Simpson ML; Janbain M; Konkle BA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011441. PubMed ID: 28944952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B.
    Olasupo OO; Noronha N; Lowe MS; Ansel D; Bhatt M; Matino D
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD014544. PubMed ID: 38411279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors.
    Matino D; Makris M; Dwan K; D'Amico R; Iorio A
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD004449. PubMed ID: 26677005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Iorio A; Marchesini E; Marcucci M; Stobart K; Chan AK
    Cochrane Database Syst Rev; 2011 Sep; (9):CD003429. PubMed ID: 21901684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions.
    Engelen ET; Schutgens RE; Mauser-Bunschoten EP; van Es RJ; van Galen KP
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012293. PubMed ID: 29963686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for haemophilia.
    Sharma A; Easow Mathew M; Sriganesh V; Neely JA; Kalipatnapu S
    Cochrane Database Syst Rev; 2014 Nov; (11):CD010822. PubMed ID: 25394678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for haemophilia.
    Sharma A; Easow Mathew M; Sriganesh V; Reiss UM
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010822. PubMed ID: 32342499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors.
    Iorio A; Matino D; D'Amico R; Makris M
    Cochrane Database Syst Rev; 2010 Aug; (8):CD004449. PubMed ID: 20687076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for haemophilia.
    Sharma A; Easow Mathew M; Sriganesh V; Reiss UM
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010822. PubMed ID: 27996087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for treating inhibitors in people with inherited severe hemophilia.
    Jiang L; Liu Y; Zhang L; Santoro C; Rodriguez A
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010810. PubMed ID: 28685500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for treating inhibitors in people with inherited severe hemophilia.
    Jiang L; Liu Y; Zhang L; Santoro C; Rodriguez A
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD010810. PubMed ID: 32761818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab for treating inhibitors in people with inherited severe hemophilia.
    Liu Y; Zhang L; Santoro C; Song J; Rodriguez A; Wang L
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010810. PubMed ID: 25841099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Stobart K; Iorio A; Wu JK
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003429. PubMed ID: 16625581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise for haemophilia.
    Strike K; Mulder K; Michael R
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD011180. PubMed ID: 27992070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.